Literature DB >> 25542934

Sonographic and cytopathologic correlation of papillary thyroid carcinoma variants.

Ji Hyun Lee1, Jung Hee Shin2, Hyun-Woo Lee2, Young Lyun Oh2, Soo Yeon Hahn2, Eun Young Ko2.   

Abstract

Papillary thyroid carcinoma (PTC) is the most common thyroid cancer and constitutes more than 70% of thyroid malignancies. Although TNM staging is the most widely used parameter for determination of therapeutic plans, recent studies have suggested that different histopathologic variants of PTC can also have different clinical courses and patient prognoses. Sonographic criteria for PTC are well established and include a taller-than-wide shape, an irregular margin, microcalcifications, and marked hypoechogenicity. The role of sonography has expanded to enable the characterization of PTC variants based on their sonographic features. Tall cell and diffuse sclerosing variants appear to have more aggressive clinical courses with unfavorable prognoses, whereas the more recently described cribriform-morular and Warthin-like variants have relatively indolent clinical courses. The prognoses of patients with follicular, solid, columnar cell, and oncocytic variants are still controversial and may be similar to the prognosis of conventional PTC. Understanding the sonographic characteristics of PTC variants with clinicopathologic correlation may be helpful for suggesting an appropriate treatment plan.
© 2015 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  cytology; papillary thyroid carcinoma; pathology; sonography; thyroid neoplasm

Mesh:

Year:  2015        PMID: 25542934     DOI: 10.7863/ultra.34.1.1

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  7 in total

1.  Analysis of Malignant Thyroid Neoplasms with a Striking Rise of Papillary Microcarcinoma in an Endemic Goiter Region.

Authors:  Alka Mary Mathai; K Preetha; S Valsala Devi; Sam Vicliph; Raja Pradeep; Aqib Shaick
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-07-20

2.  Columnar Cell Variant of Papillary Thyroid Carcinoma: Ultrasonographic and Clinical Differentiation between the Indolent and Aggressive Types.

Authors:  Jooyeon Cho; Jung Hee Shin; Soo Yeon Hahn; Young Lyun Oh
Journal:  Korean J Radiol       Date:  2018-08-06       Impact factor: 3.500

3.  Depletion of VAX2 Restrains the Malignant Progression of Papillary Thyroid Carcinoma by Modulating ERK Signaling Pathway.

Authors:  Bei Guo; Yi Zhang; Kun Yuan; Feng-Xia Jiang; Qian-Bo Cui; Qin Zhou; Hong-Xia Dong; Wei Chen; Shun-Shi Yang
Journal:  Open Life Sci       Date:  2019-07-10       Impact factor: 0.938

4.  The Combined Utility of HBME-1 and Galectin-3 Immunohistochemistry and BRAF V600E Mutations in the Diagnosis of Papillary Thyroid Carcinoma.

Authors:  Subramaniam Ramkumar; Shanthakumari Sivanandham
Journal:  Cureus       Date:  2021-12-10

5.  A beneficial role of computer-aided diagnosis system for less experienced physicians in the diagnosis of thyroid nodule on ultrasound.

Authors:  Sunyoung Kang; Eunjung Lee; Chae Won Chung; Han Na Jang; Joon Ho Moon; Yujin Shin; Kyuho Kim; Ying Li; Soo Myoung Shin; Yoo Hyung Kim; Seul Ki Kwon; Chang Ho Ahn; Kyong Yeun Jung; A Ram Hong; Young Joo Park; Do Joon Park; Jin Young Kwak; Sun Wook Cho
Journal:  Sci Rep       Date:  2021-10-14       Impact factor: 4.379

6.  Diagnostic significance of CK19, galectin-3, CD56, TPO and Ki67 expression and BRAF mutation in papillary thyroid carcinoma.

Authors:  Lihua Huang; Xuming Wang; Xuan Huang; Huawei Gui; Yan Li; Qiongxia Chen; Dongling Liu; Lijiang Liu
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

7.  Ultrasonographic Features of Papillary Thyroid Carcinomas According to Their Subtypes.

Authors:  Hye Jin Baek; Dong Wook Kim; Gi Won Shin; Young Jin Heo; Jin Wook Baek; Yoo Jin Lee; Young Jun Cho; Ha Kyoung Park; Tae Kwun Ha; Do Hun Kim; Soo Jin Jung; Ji Sun Park; Ki Jung Ahn
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-08       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.